Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

Mesalazine-Mesalamine-5-aminosalicylic acid-5ASA-5-aminosalicylate

II - Myocardial dysfunction - Heart failure

II.a

Left ventricular dysfunction/failure
II.d

Cardiovascular collapse - Cardiogenic shock - Hypotension

III - Myocardial ischemia - Coronary artery disease

III.a

Coronary artery disease (acute) - Myocardial ischemia/infarction

V - Myocarditis

V.a

Myocarditis (can be fulminate/fulminant)
V.b

Eosinophilic myocarditis
V.f

Myopericarditis

X - Pulmonary edema

X.a

Pulmonary edema, cardiogenic

XII - Pericardial involvement

XII.a

Pericarditis
XII.b

Pericardial effusion (w/wo tamponade)
XII.n

Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV.d

Eosinophilic pleural effusion

XV - Chest pain

XV.a

Chest pain (acute or subacute), lone or prominent

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)
XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.d

Acute eosinophilic pneumonia (AEP)
XXIV.j

Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.p

An area or areas of consolidation
XXIV.s

ILD with a granulomatous component

XXVIII - Large airway involvement

XXVIII.m

Bronchiectasis

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.b

Lupus - Lupus syndrome
XXXVI.m

DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome